Telix Pharmaceuticals Ltd has released a press release.
Update - prostate imaging program
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Drug Master File for Prostate Imaging Product Filed with FDA
- Telix and Radboud University Medical Centre Collaboration
- Appendix 4E and 2017 Annual Report
- Shareholder Update
- Appendix 4C - December 2017 quarter
Later from Telix Pharmaceuticals
- Telix JV Entity Contract with Endocyte for Prostate Imaging
- Translational Research Partnership with INSERM and ARRONAX
- Appendix 4C - March 2018 quarter
- Telix and Osaka U receive funding for Alpha Nuclide Research
- SEIF Grant Awarded for Advanced Biologics Manufacturing
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals